Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Thomas Tursz

Showing results (31-40 of 42) with videos related to

Pageof 5
Sort By:
The New England Journal of Medicine|September 8, 2006
DNA repair by ERCC1 in non-small-cell lung cancer and cisplatin-based adjuvant chemotherapyKen A Olaussen, Ariane Dunant, Pierre Fouret, et al.
Journal of Immunology (Baltimore, Md. : 1950)|February 7, 2004
Exosomes as potent cell-free peptide-based vaccine. II. Exosomes in CpG adjuvants efficiently prime naive Tc1 lymphocytes leading to tumor rejectionNathalie Chaput, Nöel E C Schartz, Fabrice André, et al.
Journal of the National Cancer Institute|April 6, 2006
Gene expression profiling of primary cutaneous melanoma and clinical outcomeVéronique Winnepenninckx, Vladimir Lazar, Stefan Michiels, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 30, 2005
Catalytic subunit of human telomerase reverse transcriptase is an independent predictor of survival in patients undergoing curative resection of hepatic colorectal metastases: a multicenter analysisJulien Dômont, Timothy M Pawlik, Valérie Boige, et al.
Molecular Oncology|April 23, 2009
MYCN-non-amplified metastatic neuroblastoma with good prognosis and spontaneous regression: a molecular portrait of stage 4SJean Bénard, Gilda Raguénez, Audrey Kauffmann, et al.
The Journal of Experimental Medicine|October 19, 2005
CD4+CD25+ regulatory T cells inhibit natural killer cell functions in a transforming growth factor-beta-dependent mannerFrançois Ghiringhelli, Cédric Ménard, Magali Terme, et al.
Journal of Translational Medicine|March 3, 2005
Vaccination of metastatic melanoma patients with autologous dendritic cell (DC) derived-exosomes: results of thefirst phase I clinical trialBernard Escudier, Thierry Dorval, Nathalie Chaput, et al.
Nature Medicine|January 31, 2006
A novel dendritic cell subset involved in tumor immunosurveillanceJulien Taieb, Nathalie Chaput, Cédric Ménard, et al.
The Journal of Clinical Investigation|August 3, 2004
Novel mode of action of c-kit tyrosine kinase inhibitors leading to NK cell-dependent antitumor effectsChristophe Borg, Magali Terme, Julien Taïeb, et al.
Nature Medicine|August 21, 2007
Toll-like receptor 4-dependent contribution of the immune system to anticancer chemotherapy and radiotherapyLionel Apetoh, François Ghiringhelli, Antoine Tesniere, et al.
Pageof 5

Showing results (31-40 of 42) with videos related to

Sort By:
Pageof 5
The New England Journal of Medicine|September 8, 2006
DNA repair by ERCC1 in non-small-cell lung cancer and cisplatin-based adjuvant chemotherapyKen A Olaussen, Ariane Dunant, Pierre Fouret, et al.
Journal of Immunology (Baltimore, Md. : 1950)|February 7, 2004
Exosomes as potent cell-free peptide-based vaccine. II. Exosomes in CpG adjuvants efficiently prime naive Tc1 lymphocytes leading to tumor rejectionNathalie Chaput, Nöel E C Schartz, Fabrice André, et al.
Journal of the National Cancer Institute|April 6, 2006
Gene expression profiling of primary cutaneous melanoma and clinical outcomeVéronique Winnepenninckx, Vladimir Lazar, Stefan Michiels, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 30, 2005
Catalytic subunit of human telomerase reverse transcriptase is an independent predictor of survival in patients undergoing curative resection of hepatic colorectal metastases: a multicenter analysisJulien Dômont, Timothy M Pawlik, Valérie Boige, et al.
Molecular Oncology|April 23, 2009
MYCN-non-amplified metastatic neuroblastoma with good prognosis and spontaneous regression: a molecular portrait of stage 4SJean Bénard, Gilda Raguénez, Audrey Kauffmann, et al.
The Journal of Experimental Medicine|October 19, 2005
CD4+CD25+ regulatory T cells inhibit natural killer cell functions in a transforming growth factor-beta-dependent mannerFrançois Ghiringhelli, Cédric Ménard, Magali Terme, et al.
Journal of Translational Medicine|March 3, 2005
Vaccination of metastatic melanoma patients with autologous dendritic cell (DC) derived-exosomes: results of thefirst phase I clinical trialBernard Escudier, Thierry Dorval, Nathalie Chaput, et al.
Nature Medicine|January 31, 2006
A novel dendritic cell subset involved in tumor immunosurveillanceJulien Taieb, Nathalie Chaput, Cédric Ménard, et al.
The Journal of Clinical Investigation|August 3, 2004
Novel mode of action of c-kit tyrosine kinase inhibitors leading to NK cell-dependent antitumor effectsChristophe Borg, Magali Terme, Julien Taïeb, et al.
Nature Medicine|August 21, 2007
Toll-like receptor 4-dependent contribution of the immune system to anticancer chemotherapy and radiotherapyLionel Apetoh, François Ghiringhelli, Antoine Tesniere, et al.
Pageof 5